{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:54:53Z","timestamp":1790978093658,"version":"4.1.0"},"reference-count":60,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The era of targeted therapies has seen significant improvements in depth of response, progression-free survival, and overall survival for patients with multiple myeloma. Despite these improvements in clinical outcome, patients inevitably relapse and require further treatment. Drug-resistant dormant myeloma cells that reside in specific niches within the skeleton are considered a basis of disease relapse but remain elusive and difficult to study. Here, we developed a method to sequence the transcriptome of individual dormant myeloma cells from the bones of tumor-bearing mice. Our analyses show that dormant myeloma cells express a distinct transcriptome signature enriched for immune genes and, unexpectedly, genes associated with myeloid cell differentiation. These genes were switched on by coculture with osteoblastic cells. Targeting AXL, a gene highly expressed by dormant cells, using small-molecule inhibitors released cells from dormancy and promoted their proliferation. Analysis of the expression of AXL and coregulated genes in human cohorts showed that healthy human controls and patients with monoclonal gammopathy of uncertain significance expressed higher levels of the dormancy signature genes than patients with multiple myeloma. Furthermore, in patients with multiple myeloma, the expression of this myeloid transcriptome signature translated into a twofold increase in overall survival, indicating that this dormancy signature may be a marker of disease progression. Thus, engagement of myeloma cells with the osteoblastic niche induces expression of a suite of myeloid genes that predicts disease progression and that comprises potential drug targets to eradicate dormant myeloma cells.<\/jats:p>","DOI":"10.1182\/blood.2018880930","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T21:06:32Z","timestamp":1556226392000},"page":"30-43","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":135,"title":["A niche-dependent myeloid transcriptome signature defines dormant myeloma cells"],"prefix":"10.1182","volume":"134","author":[{"given":"Weng Hua","family":"Khoo","sequence":"first","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"},{"name":"School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-6066","authenticated-orcid":false,"given":"Guy","family":"Ledergor","sequence":"additional","affiliation":[{"name":"Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;"},{"name":"Department of Internal Medicine \u201cT\u201d, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Weiner","sequence":"additional","affiliation":[{"name":"Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Roden","sequence":"additional","affiliation":[{"name":"Cancer Division, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-7372","authenticated-orcid":false,"given":"Rachael L.","family":"Terry","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"},{"name":"St Vincent\u2019s Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Chai","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"De Veirman","sequence":"additional","affiliation":[{"name":"Department of Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L.","family":"Owen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Genetics, La Trobe University, Melbourne, VIC, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khatora S.","family":"Opperman","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia;"},{"name":"Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1033-849X","authenticated-orcid":false,"given":"Kate","family":"Vandyke","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia;"},{"name":"Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine R.","family":"Clark","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia;"},{"name":"Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2771-712X","authenticated-orcid":false,"given":"Anja","family":"Seckinger","sequence":"additional","affiliation":[{"name":"Labor f\u00fcr Myelomforschung, Medizinische Klinik V, Universit\u00e4tsklinikum Heidelberg, Ruprecht-Karls-Universit\u00e4t Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Kovacic","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Clinical Anatomy, University of Zagreb School of Medicine, Zagreb, Croatia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nguyen","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia;"},{"name":"Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu T.","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Pettitt","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Xiao","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8450-012X","authenticated-orcid":false,"given":"Alexander P.","family":"Corr","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"},{"name":"St Vincent\u2019s Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Seeliger","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Novotny","sequence":"additional","affiliation":[{"name":"J. Craig Venter Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Lasken","sequence":"additional","affiliation":[{"name":"J. Craig Venter Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3246-6281","authenticated-orcid":false,"given":"Tuan V.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"},{"name":"St Vincent\u2019s Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia;"},{"name":"School of Biomedical Engineering, University of Technology, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde O.","family":"Oyajobi","sequence":"additional","affiliation":[{"name":"Department of Cell Systems and Anatomy, Long School of Medicine, and"},{"name":"Mays Cancer Center, University of Texas Health Science Center, San Antonio, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Aftab","sequence":"additional","affiliation":[{"name":"Exelixis Inc, Alameda, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-5676","authenticated-orcid":false,"given":"Alexander","family":"Swarbrick","sequence":"additional","affiliation":[{"name":"Cancer Division, Garvan Institute of Medical Research, Sydney, NSW, Australia;"},{"name":"St Vincent\u2019s Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Genetics, La Trobe University, Melbourne, VIC, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan R.","family":"Hewett","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia;"},{"name":"Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[{"name":"Labor f\u00fcr Myelomforschung, Medizinische Klinik V, Universit\u00e4tsklinikum Heidelberg, Ruprecht-Karls-Universit\u00e4t Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Vanderkerken","sequence":"additional","affiliation":[{"name":"Department of Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C. W.","family":"Zannettino","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia;"},{"name":"Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Amit","sequence":"additional","affiliation":[{"name":"Department of Immunology, Weizmann Institute of Science, Rehovot, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-2984","authenticated-orcid":false,"given":"Tri Giang","family":"Phan","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia;"},{"name":"Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-2413","authenticated-orcid":false,"given":"Peter I.","family":"Croucher","sequence":"additional","affiliation":[{"name":"Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, Australia;"},{"name":"School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia;"},{"name":"St Vincent\u2019s Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021109222949300_B1","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2020021109222949300_B2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2012-01-379024","article-title":"Myeloma as a model for the process of metastasis: implications for therapy","volume":"120","author":"Ghobrial","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2020021109222949300_B3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40265-017-0841-y","article-title":"Current and new therapeutic strategies for relapsed and refractory multiple myeloma: an update","volume":"78","author":"Nijhof","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"2020021109222949300_B4","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"2020021109222949300_B5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone metastasis: the importance of the neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2020021109222949300_B6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2020021109222949300_B7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrc3910","article-title":"Metastasis prevention by targeting the dormant niche","volume":"15","author":"Ghajar","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"340","key":"2020021109222949300_B8","doi-asserted-by":"crossref","first-page":"340ra73","DOI":"10.1126\/scitranslmed.aad4059","article-title":"Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone","volume":"8","author":"Price","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"2020021109222949300_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2010.168","article-title":"In vivo imaging of transplanted hematopoietic stem and progenitor cells in mouse calvarium bone marrow","volume":"6","author":"Lo Celso","year":"2011","journal-title":"Nat Protoc"},{"issue":"2","key":"2020021109222949300_B10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ni.2796","article-title":"Single-cell technologies for monitoring immune systems","volume":"15","author":"Chattopadhyay","year":"2014","journal-title":"Nat Immunol"},{"key":"2020021109222949300_B11","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3389\/fimmu.2018.01553","article-title":"Single cell RNA sequencing of rare immune cell populations","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"2020021109222949300_B12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nm.4336","article-title":"Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia","volume":"23","author":"Giustacchini","year":"2017","journal-title":"Nat Med"},{"issue":"14","key":"2020021109222949300_B13","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1182\/blood-2013-07-517136","article-title":"Osteoblastic niche supports the growth of quiescent multiple myeloma cells","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2020021109222949300_B14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1158\/1535-7163.MCT-07-0121","article-title":"Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging","volume":"6","author":"Oyajobi","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"2020021109222949300_B15","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/pros.21010","article-title":"A novel model of bone-metastatic prostate cancer in immunocompetent mice","volume":"69","author":"Power","year":"2009","journal-title":"Prostate"},{"issue":"1","key":"2020021109222949300_B16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nmeth.2694","article-title":"Quantitative assessment of single-cell RNA-sequencing methods","volume":"11","author":"Wu","year":"2014","journal-title":"Nat Methods"},{"issue":"5","key":"2020021109222949300_B17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat Methods"},{"issue":"web server issue","key":"2020021109222949300_B18","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2020021109222949300_B19","doi-asserted-by":"crossref","first-page":"e1004333","DOI":"10.1371\/journal.pcbi.1004333","article-title":"BASiCS: Bayesian Analysis of Single-Cell Sequencing Data","volume":"11","author":"Vallejos","year":"2015","journal-title":"PLOS Comput Biol"},{"issue":"1","key":"2020021109222949300_B20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13059-016-0930-3","article-title":"Beyond comparisons of means: understanding changes in gene expression at the single-cell level","volume":"17","author":"Vallejos","year":"2016","journal-title":"Genome Biol"},{"issue":"5","key":"2020021109222949300_B21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2020021109222949300_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2020021109222949300_B23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"2020021109222949300_B24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2105-11-367","article-title":"A flexible R package for nonnegative matrix factorization","volume":"11","author":"Gaujoux","year":"2010","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"2020021109222949300_B25","doi-asserted-by":"crossref","first-page":"e1003731","DOI":"10.1371\/journal.pcbi.1003731","article-title":"iRegulon: from a gene list to a gene regulatory network using large motif and track collections","volume":"10","author":"Janky","year":"2014","journal-title":"PLOS Comput Biol"},{"issue":"11","key":"2020021109222949300_B26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"2020021109222949300_B27","doi-asserted-by":"crossref","article-title":"Gephi: an open source software for exploring and manipulating networks.","author":"Bastian","DOI":"10.1609\/icwsm.v3i1.13937"},{"issue":"7","key":"2020021109222949300_B28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"2020021109222949300_B29","doi-asserted-by":"crossref","DOI":"10.1117\/12.935640","article-title":"a volume exploration and presentation tool","volume":"85060X","author":"Limaye","year":"2012","journal-title":"Proc. SPIE 8506, Developments in X-Ray Tomography VIII"},{"issue":"12","key":"2020021109222949300_B30","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"2020021109222949300_B31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3324\/haematol.2009.015628","article-title":"Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells","volume":"95","author":"Martin","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"2020021109222949300_B32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ccell.2017.02.002","article-title":"Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment","volume":"31","author":"Seckinger","year":"2017","journal-title":"Cancer Cell"},{"issue":"7","key":"2020021109222949300_B33","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1158\/0008-5472.CAN-06-4046","article-title":"Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling","volume":"67","author":"Chng","year":"2007","journal-title":"Cancer Res"},{"issue":"8","key":"2020021109222949300_B34","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib","volume":"109","author":"Mulligan","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2020021109222949300_B35","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2012-03-415588","article-title":"Clinical and prognostic role of annexin A2 in multiple myeloma","volume":"120","author":"Seckinger","year":"2012","journal-title":"Blood"},{"key":"2020021109222949300_B36","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3389\/fimmu.2018.01676","article-title":"CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma: association with molecular entities, risk, survival, and mechanisms of upfront resistance","volume":"9","author":"Seckinger","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"2020021109222949300_B37","first-page":"593","article-title":"Animal model of human disease Multiple myeloma","volume":"132","author":"Radl","year":"1988","journal-title":"Am J Pathol"},{"issue":"6","key":"2020021109222949300_B38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S8756-3282(97)00056-2","article-title":"A murine model of human myeloma bone disease","volume":"20","author":"Garrett","year":"1997","journal-title":"Bone"},{"issue":"12","key":"2020021109222949300_B39","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.0308531101","article-title":"Metagenes and molecular pattern discovery using matrix factorization","volume":"101","author":"Brunet","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"database issue","key":"2020021109222949300_B40","first-page":"D1040","article-title":"Interferome v20: an updated database of annotated interferon-regulated genes","volume":"41","author":"Rusinova","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"35","key":"2020021109222949300_B41","doi-asserted-by":"crossref","first-page":"22719","DOI":"10.1074\/jbc.273.35.22719","article-title":"High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages","volume":"273","author":"Veillette","year":"1998","journal-title":"J Biol Chem"},{"issue":"6","key":"2020021109222949300_B42","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V85.6.1620.bloodjournal8561620","article-title":"Isolation of a novel macrophage-specific gene by differential cDNA analysis","volume":"85","author":"Spilsbury","year":"1995","journal-title":"Blood"},{"issue":"11","key":"2020021109222949300_B43","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2008-07-171967","article-title":"Zebrafish granulocyte colony-stimulating factor receptor signaling promotes myelopoiesis and myeloid cell migration","volume":"113","author":"Liongue","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2020021109222949300_B44","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0045-2016","article-title":"The role and function of Fc\u03b3 receptors on myeloid cells","volume":"4","author":"Bournazos","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"5","key":"2020021109222949300_B45","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1038\/cddis.2013.147","article-title":"Modeling cell-in-cell structure into its biological significance","volume":"4","author":"He","year":"2013","journal-title":"Cell Death Dis"},{"issue":"5","key":"2020021109222949300_B46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1535-6108(03)00114-4","article-title":"Cell fusion: a hidden enemy?","volume":"3","author":"Duelli","year":"2003","journal-title":"Cancer Cell"},{"issue":"5","key":"2020021109222949300_B47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.thj.6200052","article-title":"The 5TMM series: a useful in vivo mouse model of human multiple myeloma","volume":"1","author":"Asosingh","year":"2000","journal-title":"Hematol J"},{"issue":"12","key":"2020021109222949300_B48","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1535-7163.MCT-11-0264","article-title":"Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth","volume":"10","author":"Yakes","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"2020021109222949300_B49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/jm801586s","article-title":"Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily","volume":"52","author":"Schroeder","year":"2009","journal-title":"J Med Chem"},{"issue":"2","key":"2020021109222949300_B50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1593\/neo.91384","article-title":"GAS6\/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche","volume":"12","author":"Shiozawa","year":"2010","journal-title":"Neoplasia"},{"issue":"8","key":"2020021109222949300_B51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jcp.45.8.645","article-title":"Histology of normal haemopoiesis: bone marrow histology I","volume":"45","author":"Wilkins","year":"1992","journal-title":"J Clin Pathol"},{"issue":"11","key":"2020021109222949300_B52","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1158\/1078-0432.CCR-16-1298","article-title":"Gas6\/AXL signaling regulates self-renewal of chronic myelogenous leukemia stem cells by stabilizing \u03b2-catenin","volume":"23","author":"Jin","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2020021109222949300_B53","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nm.2830","article-title":"Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape","volume":"18","author":"Bidwell","year":"2012","journal-title":"Nat Med"},{"issue":"5","key":"2020021109222949300_B54","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.celrep.2018.04.019","article-title":"The receptor tyrosine kinase AXL is required at multiple steps of the metastatic cascade during HER2-positive breast cancer progression","volume":"23","author":"Goyette","year":"2018","journal-title":"Cell Reports"},{"issue":"1","key":"2020021109222949300_B55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/0008-5472.CAN-17-1973","article-title":"Small-molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer","volume":"78","author":"Ludwig","year":"2018","journal-title":"Cancer Res"},{"issue":"12","key":"2020021109222949300_B56","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1158\/1535-7163.MCT-17-0587","article-title":"Inhibition of the receptor tyrosine kinase AXL restores paclitaxel chemosensitivity in uterine serous cancer","volume":"16","author":"Palisoul","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"2020021109222949300_B57","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1158\/0008-5472.CAN-17-0392","article-title":"AXL-driven EMT state as a targetable conduit in cancer","volume":"77","author":"Antony","year":"2017","journal-title":"Cancer Res"},{"issue":"19","key":"2020021109222949300_B58","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2016-01-694786","article-title":"Phase IB study of cabozantinib in patients with relapsed and\/or refractory multiple myeloma","volume":"127","author":"Lendvai","year":"2016","journal-title":"Blood"},{"key":"2020021109222949300_B59","author":"Suominen"},{"issue":"1","key":"2020021109222949300_B60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2010.030296","article-title":"Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma","volume":"96","author":"Hose","year":"2011","journal-title":"Haematologica"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/1\/30\/1553831\/blood880930.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/1\/30\/1553831\/blood880930.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:21:55Z","timestamp":1694816515000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/1\/30\/260664\/A-nichedependent-myeloid-transcriptome-signature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2018880930","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]}}}